{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-22-000088","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.755611+00:00","generated_at":"2026-06-24T07:56:04.397965+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teleflex Q2 revenue $704.5M (-1.3% YoY); FY2022 adjusted EPS guidance cut to $13.00-$13.40 from $13.70-$14.30","bullets":["Revenue $704.5M, down 1.3% YoY; constant currency growth +2.3%.","GAAP diluted EPS $2.23 vs $1.76 prior year; adjusted EPS $3.39 vs $3.35.","Interventional Urology revenue fell 13.5% YoY on constant currency basis.","FY2022 adjusted EPS guidance lowered to $13.00-$13.40 from $13.70-$14.30.","Constant currency revenue growth guidance reduced to 3.25%-4.25% from 4.0%-5.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-22-000088","json":"https://secwatch.observer/filing/0000096943-22-000088.json","markdown":"https://secwatch.observer/filing/0000096943-22-000088.md","text":"https://secwatch.observer/filing/0000096943-22-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694322000088/0000096943-22-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694322000088/tfx-20220728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:56:04.397965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}